Pharmacokinetics of a parenteral carbapenem antibiotic, biapenem, in Chinese healthy volunteers

Chinese Journal of Antibiotics

Volumn 33, Issue 12, 2008, Pages 717-720

  Deng, Li ^a   Huang, Wen Xiang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Biapenem; HPLC; Pharmacokinetics

Indexed keywords

BIAPENEM;

AREA UNDER THE CURVE; ARTICLE; CHINESE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; SINGLE DRUG DOSE;

EID: 61349202184     PISSN: 10018689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Petersen P J, Jacobus N V, Weiss W J, et al. In vitro and in vivo activities of LJC10, 627, a new carbapenem with stability to dehydropeptidase I [J]- Antimicrob Agents Chemother, 1991, 35(1):203-207.
2. Malanoski G J, Collins L, Wennersten C, et al. In vitro activity of biapenem against clinical isolates of Gram-positive and Gram-negative bacteria [J]. Antimicrob Agents Chemother, 1993, 37(9):2009-2016.
3. Koeppe P, Hoeffler D, Fitzen B. Biapenem pharmacokinetics in healthy volunteers and in patients with impaired renal function [J]. Arzneimittel-Forschung, 1997, 47(11):1250-1256.
4. Kozawa O, Uematsu T, Matsuno H, et al. Pharmacokinetics and safety of a new parenteral carbapenem antibiotic, biapenem (L-627), in elderly subjects [J]. Antimicrob Agents Chemother, 1998, 42(6):1433-1436.
5. Chinese source
6. Nagashima S, Kozawa O, Otsuka T, et al. Pharmacokinetics of a parenteral carbapenem, biapenem, in patients with end-stage renal disease and influence of haemodialysis [J]. J Antimicrob Chemother, 2000,46(5): 839-842.
7. Nakashima M, Uematsu T, Ueno K, et al. Phase I study of L-627, biapenem, a new parenteral carbapenem antibiotic [J]. Int J Clin Pharmacol Ther Toxicol, 1993,31(2): 70-76.